Speaker illustration

Doctor Gabor Antal Simonyi

St Imre University Teaching Hospital, Budapest (Hungary)

Patients adherence with fixed dose combinations of renin-angiotensin-aldosterone system inhibitors in hypertension.

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Hypertension treatment: drugs and devices

Thumbnail

Advantage of novel oral anticoagulants compared to vitamin-K antagonist in atrial fibrillation. Data from real world.

Event: ESC Congress 2018

Topic: Oral Anticoagulation

Session: Atrial fibrillation - Stroke prevention 2

Thumbnail

Fixed combinations of renin-angiotensin-aldosterone system inhibitors and calcium channel blockers in relation of patients adherence in hypertension

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Hypertension treatment old and new

Thumbnail

Which is the best choice? One year persistence of ramipril, ramipril/amlodipin free and fixed dose combination therapy in hypertension

Event: ESC Congress 2017

Topic: Treatment of hypertension

Session: Hypertension drug treatment

Thumbnail

Persistence of fixed and free combination of perindopril and amlodipine in hypertension

Event: ESC Congress 2016

Topic: Treatment of hypertension

Session: Drug treatment of hypertension

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb